News Focus
News Focus
icon url

Burn Notice88

05/29/15 4:17 PM

#84273 RE: Steve White #84265

Third most-rediculous Bud Genius statement of the day...

You left out Matt Dwyer Bcap and the debt still exits


*Long Term Debt: None

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=113510888

05/29/2015

http://www.otcmarkets.com/financialReportViewer?symbol=RIGH&id=129668

http://www.otcmarkets.com/financialReportViewer?symbol=RIGH&id=125532

A/O 09/30/2014
Current Assets: $1,183,607

Revenue: $54,684

*Long Term Debt: None

Per the Third Quarter 2014 filing.........

http://www.otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=129668

Item III: Security Information
Trading Symbol: RIGH
Exact Title and Class of Securities Outs.: Common Stock
CUSIP: 76657X 10 3
Total Shares Auth. as of September 30, 2014: 30,000,000,000
Total Shares Issued as of September 30, 2014: 28,060,999,468
Total Shares Outstanding as of June 30, 2014: 29,999,999,468

OTHER INFO ABOUT BUD GENIUS, INC.:

1) Revenue nearly tripled from $12,200 (in Q2) to $32,385 (in Q3).

2) The company has Cash & Cash Equivalents of $74,045.

3) The company's headquarters is Genius @ Airport Plaza, 5963 La Place Court, Suite 304, Carlsbad, CA 92008.

4) The number of strain tests have increased from 188 (2013) to 267 (2014) to 115 (in 125 days/2015).

5) Bud Genius’ Balance Sheet shows a net worth of $1.1 million (after subtracting liabilities).

6) Bud Genius, Inc. has no long term debt which is a tribute to sound management. With no long term debt the company has no burden of meeting interest payments. And this makes it less likely to have financial problems in the future.

* Note: Clean Balance Sheet. No Long-Term Debt.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=112209279

7) On March 30th, 2015, the company announced LOI to Acquire Evergreen Licensing – an Exclusive Licensor of Tommy Chong Products. The Company controls licensing rights in the nation’s largest cannabis market, with $1.3 billion in yearly sales.

8) The company shows a balance remaining of 24,716,792,728 shares common stock that were issued to one shareholder in November 2013.

9) The company repurchased 1.499 billion shares of its own stock, almost 5% of the company’s outstanding shares in September 2014.

10) The company repurchased an additional 500,000,000 shares of its own stock in September 2014.

11) "The company “feels the number of outstanding shares is too high… and is presently in discussion about ways to do more. As buybacks occur, the shares will be cancelled and the board will complete a resolution to reduce the authorized shares." - http://bgmedtech.com/

Other useful links:

http://bgmedtech.com/bud-genius-announces-share-repurchase/

http://bgmedtech.com/

http://bgmedtech.com/contact/

http://angelstanz.com/

http://budgenius.com/

- Revenue: http://bit.ly/19MgynC
- Number of strain tests: http://bit.ly/1Igp0uO
- Potential contracts: http://bit.ly/1RcCMRI
- Improved balance sheet: http://bit.ly/1G3njzV

- All convertible debt gone: http://bit.ly/1G3njzV
- Outstanding Shares being reduced: http://bit.ly/1JqDZiQ